These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 24932007)
1. Robust clinical outcome prediction based on Bayesian analysis of transcriptional profiles and prior causal networks. Zarringhalam K; Enayetallah A; Reddy P; Ziemek D Bioinformatics; 2014 Jun; 30(12):i69-77. PubMed ID: 24932007 [TBL] [Abstract][Full Text] [Related]
2. A biological network-based regularized artificial neural network model for robust phenotype prediction from gene expression data. Kang T; Ding W; Zhang L; Ziemek D; Zarringhalam K BMC Bioinformatics; 2017 Dec; 18(1):565. PubMed ID: 29258445 [TBL] [Abstract][Full Text] [Related]
3. Genes associated with intestinal permeability in ulcerative colitis: changes in expression following infliximab therapy. Toedter G; Li K; Sague S; Ma K; Marano C; Macoritto M; Park J; Deehan R; Matthews A; Wu GD; Lewis JD; Arijs I; Rutgeerts P; Baribaud F Inflamm Bowel Dis; 2012 Aug; 18(8):1399-410. PubMed ID: 22223479 [TBL] [Abstract][Full Text] [Related]
4. A Bayesian framework for inference of the genotype-phenotype map for segregating populations. Hageman RS; Leduc MS; Korstanje R; Paigen B; Churchill GA Genetics; 2011 Apr; 187(4):1163-70. PubMed ID: 21242536 [TBL] [Abstract][Full Text] [Related]
5. Inferring cellular regulatory networks with Bayesian model averaging for linear regression (BMALR). Huang X; Zi Z Mol Biosyst; 2014 Aug; 10(8):2023-30. PubMed ID: 24899235 [TBL] [Abstract][Full Text] [Related]
6. Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis. Arijs I; Li K; Toedter G; Quintens R; Van Lommel L; Van Steen K; Leemans P; De Hertogh G; Lemaire K; Ferrante M; Schnitzler F; Thorrez L; Ma K; Song XY; Marano C; Van Assche G; Vermeire S; Geboes K; Schuit F; Baribaud F; Rutgeerts P Gut; 2009 Dec; 58(12):1612-9. PubMed ID: 19700435 [TBL] [Abstract][Full Text] [Related]
7. Integrating gene set analysis and nonlinear predictive modeling of disease phenotypes using a Bayesian multitask formulation. Gönen M BMC Bioinformatics; 2016 Dec; 17(Suppl 16):0. PubMed ID: 28105911 [TBL] [Abstract][Full Text] [Related]
8. Real-life treatment paradigms show infliximab is cost-effective for management of ulcerative colitis. Ung V; Thanh NX; Wong K; Kroeker KI; Lee T; Wang H; Ohinmaa A; Jacobs P; Fedorak RN Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1871-8.e8. PubMed ID: 24674943 [TBL] [Abstract][Full Text] [Related]
9. Inferring microRNA and transcription factor regulatory networks in heterogeneous data. Le TD; Liu L; Liu B; Tsykin A; Goodall GJ; Satou K; Li J BMC Bioinformatics; 2013 Mar; 14():92. PubMed ID: 23497388 [TBL] [Abstract][Full Text] [Related]
10. F-MAP: A Bayesian approach to infer the gene regulatory network using external hints. Shahdoust M; Pezeshk H; Mahjub H; Sadeghi M PLoS One; 2017; 12(9):e0184795. PubMed ID: 28938012 [TBL] [Abstract][Full Text] [Related]
11. Gene Expression Signature for Prediction of Golimumab Response in a Phase 2a Open-Label Trial of Patients With Ulcerative Colitis. Telesco SE; Brodmerkel C; Zhang H; Kim LL; Johanns J; Mazumder A; Li K; Baribaud F; Curran M; Strauss R; Paxson B; Plevy S; Davison T; Knight L; Dibben S; Schreiber S; Sandborn W; Rutgeerts P; Siegel CA; Reinisch W; Greenbaum LE Gastroenterology; 2018 Oct; 155(4):1008-1011.e8. PubMed ID: 29981298 [TBL] [Abstract][Full Text] [Related]
12. An algorithm for direct causal learning of influences on patient outcomes. Rathnam C; Lee S; Jiang X Artif Intell Med; 2017 Jan; 75():1-15. PubMed ID: 28363452 [TBL] [Abstract][Full Text] [Related]
14. Prior response to infliximab and early serum drug concentrations predict effects of adalimumab in ulcerative colitis. Baert F; Vande Casteele N; Tops S; Noman M; Van Assche G; Rutgeerts P; Gils A; Vermeire S; Ferrante M Aliment Pharmacol Ther; 2014 Dec; 40(11-12):1324-32. PubMed ID: 25277873 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of infliximab for the treatment of acute exacerbations of ulcerative colitis. Punekar YS; Hawkins N Eur J Health Econ; 2010 Feb; 11(1):67-76. PubMed ID: 19844750 [TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling and response signatures associated with differential responses to infliximab treatment in ulcerative colitis. Toedter G; Li K; Marano C; Ma K; Sague S; Huang CC; Song XY; Rutgeerts P; Baribaud F Am J Gastroenterol; 2011 Jul; 106(7):1272-80. PubMed ID: 21448149 [TBL] [Abstract][Full Text] [Related]
17. Inferring active regulatory networks from gene expression data using a combination of prior knowledge and enrichment analysis. Chouvardas P; Kollias G; Nikolaou C BMC Bioinformatics; 2016 Jun; 17 Suppl 5(Suppl 5):181. PubMed ID: 27295045 [TBL] [Abstract][Full Text] [Related]
18. Discovery of gene network variability across samples representing multiple classes. Ko Y; Zhai C; Rodriguez-Zas SL Int J Bioinform Res Appl; 2010; 6(4):402-17. PubMed ID: 20940126 [TBL] [Abstract][Full Text] [Related]
19. Inference of gene pathways using mixture Bayesian networks. Ko Y; Zhai C; Rodriguez-Zas S BMC Syst Biol; 2009 May; 3():54. PubMed ID: 19454027 [TBL] [Abstract][Full Text] [Related]
20. Temporal genetic association and temporal genetic causality methods for dissecting complex networks. Lin L; Chen Q; Hirsch JP; Yoo S; Yeung K; Bumgarner RE; Tu Z; Schadt EE; Zhu J Nat Commun; 2018 Sep; 9(1):3980. PubMed ID: 30266904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]